Title Gene expression patterns in pancreatic tumors , cells andtissues

[1]  D. Botstein,et al.  Genome-Scale Identification of Membrane-Associated Human mRNAs , 2006, PLoS genetics.

[2]  L. Castello,et al.  Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor , 2005, Journal of cellular physiology.

[3]  Robert Tibshirani,et al.  Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. , 2005, Neoplasia.

[4]  Tina Hernandez-Boussard,et al.  Determination of Stromal Signatures in Breast Carcinoma , 2005, PLoS biology.

[5]  R. Tibshirani,et al.  A method for calling gains and losses in array CGH data. , 2005, Biostatistics.

[6]  D. Botstein,et al.  A DNA microarray survey of gene expression in normal human tissues , 2005, Genome Biology.

[7]  J. Cobb,et al.  Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome , 2005, Molecular Cancer.

[8]  A. Maitra,et al.  Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms , 2004, Clinical Cancer Research.

[9]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[10]  Y-Y Gu,et al.  Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs. , 2004, Endocrine-related cancer.

[11]  P. Argani,et al.  Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Tamaya,et al.  Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Rork Kuick,et al.  Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. , 2003, Cancer research.

[14]  C. Fenoglio-Preiser,et al.  Dysregulation of β-Catenin Expression Correlates With Tumor Differentiation in Pancreatic Duct Adenocarcinoma , 2003, Annals of Surgical Oncology.

[15]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[16]  David Botstein,et al.  SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data , 2003, Nucleic Acids Res..

[17]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Kathleen R. Cho,et al.  Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. , 2002, The Journal of biological chemistry.

[19]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[20]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Tatjana Crnogorac-Jurcevic,et al.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.

[22]  Choun-Ki Joo,et al.  Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.

[23]  Hans Clevers,et al.  Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.

[24]  Giovanni Parmigiani,et al.  Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. , 2002, Cancer research.

[25]  R. Hruban,et al.  Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.

[26]  Å. Lernmark,et al.  Dynamic perifusion to maintain and assess isolated pancreatic islets. , 2002, Diabetes technology & therapeutics.

[27]  J. Cameron,et al.  Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Gress,et al.  Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. , 2001, Gastroenterology.

[30]  R. Hruban,et al.  A white paper: the product of a pancreas cancer think tank. , 2001, Cancer research.

[31]  J. Cameron,et al.  Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. , 2001, Cancer research.

[32]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[34]  David Botstein,et al.  The Stanford Microarray Database , 2001, Nucleic Acids Res..

[35]  S. Knuutila,et al.  Chromosomal alterations in human pancreatic endocrine tumors , 2000, Genes, chromosomes & cancer.

[36]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[37]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[38]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[39]  H. Friess,et al.  Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. , 1999, Annals of surgery.

[40]  G. Barsh,et al.  Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. , 1999, Genomics.

[41]  S. Yamashita,et al.  Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. , 1999, Thyroid : official journal of the American Thyroid Association.

[42]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Bernheim,et al.  Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system , 1998, Genes, chromosomes & cancer.

[44]  D. Oda,et al.  Culture of human main pancreatic duct epithelial cells , 1998, In Vitro Cellular & Developmental Biology - Animal.

[45]  J. Neoptolemos,et al.  Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. , 1996, British Journal of Cancer.

[46]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[47]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.